These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26535677)

  • 21. Prevalence of AAV1 neutralizing antibodies and consequences for a clinical trial of gene transfer for advanced heart failure.
    Greenberg B; Butler J; Felker GM; Ponikowski P; Voors AA; Pogoda JM; Provost R; Guerrero J; Hajjar RJ; Zsebo KM
    Gene Ther; 2016 Mar; 23(3):313-9. PubMed ID: 26699914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene delivery of sarcoplasmic reticulum calcium ATPase inhibits ventricular remodeling in ischemic mitral regurgitation.
    Beeri R; Chaput M; Guerrero JL; Kawase Y; Yosefy C; Abedat S; Karakikes I; Morel C; Tisosky A; Sullivan S; Handschumacher MD; Gilon D; Vlahakes GJ; Hajjar RJ; Levine RA
    Circ Heart Fail; 2010 Sep; 3(5):627-34. PubMed ID: 20634484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endobronchial Aerosolized AAV1.SERCA2a Gene Therapy in a Pulmonary Hypertension Pig Model: Addressing the Lung Delivery Bottleneck.
    Bikou O; Tharakan S; Yamada KP; Kariya T; Aguero J; Gordon A; Mazurek R; Aikawa T; Kohlbrenner E; Fish KM; Hajjar RJ; Ishikawa K
    Hum Gene Ther; 2022 May; 33(9-10):550-559. PubMed ID: 35293228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design of a phase 1/2 trial of intracoronary administration of AAV1/SERCA2a in patients with heart failure.
    Hajjar RJ; Zsebo K; Deckelbaum L; Thompson C; Rudy J; Yaroshinsky A; Ly H; Kawase Y; Wagner K; Borow K; Jaski B; London B; Greenberg B; Pauly DF; Patten R; Starling R; Mancini D; Jessup M
    J Card Fail; 2008 Jun; 14(5):355-67. PubMed ID: 18514926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparison of cardiac function and expression and activity of myocardial calcium regulatory proteins in rabbit systolic and diastolic heart failure models.].
    Wang L; Zhang SJ; Wang HP; Zou C; Liu ZH
    Sheng Li Xue Bao; 2009 Dec; 61(6):551-8. PubMed ID: 20029689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intramyocardial injection of SERCA2a-expressing lentivirus improves myocardial function in doxorubicin-induced heart failure.
    Mattila M; Koskenvuo J; Söderström M; Eerola K; Savontaus M
    J Gene Med; 2016 Jul; 18(7):124-33. PubMed ID: 27203155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of sarcoplasmic reticulum calcium ATPase 2a overexpression on endoplasmic reticulum stress in cardiomyocytes].
    Dong JJ; Lu XC; Liu XH; Zhang ZY; Li XY
    Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(6):415-8. PubMed ID: 19567124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SERCA2a gene transfer improves electrocardiographic performance in aged mdx mice.
    Shin JH; Bostick B; Yue Y; Hajjar R; Duan D
    J Transl Med; 2011 Aug; 9():132. PubMed ID: 21834967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of intracoronary administration of AAV1/SERCA2a on ventricular remodelling in patients with advanced systolic heart failure: results from the AGENT-HF randomized phase 2 trial.
    Hulot JS; Salem JE; Redheuil A; Collet JP; Varnous S; Jourdain P; Logeart D; Gandjbakhch E; Bernard C; Hatem SN; Isnard R; Cluzel P; Le Feuvre C; Leprince P; Hammoudi N; Lemoine FM; Klatzmann D; Vicaut E; Komajda M; Montalescot G; Lompré AM; Hajjar RJ;
    Eur J Heart Fail; 2017 Nov; 19(11):1534-1541. PubMed ID: 28393439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Augmentation of left ventricular mechanics by recirculation-mediated AAV2/1-SERCA2a gene delivery in experimental heart failure.
    Mariani JA; Smolic A; Preovolos A; Byrne MJ; Power JM; Kaye DM
    Eur J Heart Fail; 2011 Mar; 13(3):247-53. PubMed ID: 21289077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunosuppression decreases inflammation and increases AAV6-hSERCA2a-mediated SERCA2a expression.
    Zhu X; McTiernan CF; Rajagopalan N; Shah H; Fischer D; Toyoda Y; Letts D; Bortinger J; Gibson G; Xiang W; McCurry K; Mathier M; Glorioso JC; London B
    Hum Gene Ther; 2012 Jul; 23(7):722-32. PubMed ID: 22482463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene therapy for heart failure.
    Greenberg B
    J Cardiol; 2015 Sep; 66(3):195-200. PubMed ID: 25818479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SERCA2a gene transfer enhances eNOS expression and activity in endothelial cells.
    Hadri L; Bobe R; Kawase Y; Ladage D; Ishikawa K; Atassi F; Lebeche D; Kranias EG; Leopold JA; Lompré AM; Lipskaia L; Hajjar RJ
    Mol Ther; 2010 Jul; 18(7):1284-92. PubMed ID: 20461063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of the safety and feasibility of AAV1/SERCA2a gene transfer in patients with chronic heart failure supported with a left ventricular assist device - the SERCA-LVAD TRIAL.
    Lyon AR; Babalis D; Morley-Smith AC; Hedger M; Suarez Barrientos A; Foldes G; Couch LS; Chowdhury RA; Tzortzis KN; Peters NS; Rog-Zielinska EA; Yang HY; Welch S; Bowles CT; Rahman Haley S; Bell AR; Rice A; Sasikaran T; Johnson NA; Falaschetti E; Parameshwar J; Lewis C; Tsui S; Simon A; Pepper J; Rudy JJ; Zsebo KM; Macleod KT; Terracciano CM; Hajjar RJ; Banner N; Harding SE
    Gene Ther; 2020 Dec; 27(12):579-590. PubMed ID: 32669717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac surgical delivery of the sarcoplasmic reticulum calcium ATPase rescues myocytes in ischemic heart failure.
    Fargnoli AS; Katz MG; Yarnall C; Isidro A; Petrov M; Steuerwald N; Ghosh S; Richardville KC; Hillesheim R; Williams RD; Kohlbrenner E; Stedman HH; Hajjar RJ; Bridges CR
    Ann Thorac Surg; 2013 Aug; 96(2):586-95. PubMed ID: 23773730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and efficacy of high-dose adeno-associated virus 9 encoding sarcoplasmic reticulum Ca(2+) adenosine triphosphatase delivered by molecular cardiac surgery with recirculating delivery in ovine ischemic cardiomyopathy.
    Katz MG; Fargnoli AS; Williams RD; Steuerwald NM; Isidro A; Ivanina AV; Sokolova IM; Bridges CR
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1065-72, 1073e1-2; discussion1072-3. PubMed ID: 25037619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attenuation of endoplasmic reticulum stress-related myocardial apoptosis by SERCA2a gene delivery in ischemic heart disease.
    Xin W; Lu X; Li X; Niu K; Cai J
    Mol Med; 2011; 17(3-4):201-10. PubMed ID: 21152695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reversal effect of Zhigancao decoction on myocardial fibrosis in a rapid pacing-induced atrial fibrillation model in New Zealand rabbits.
    Sun J; Wugeti N; Mahemuti A
    J Int Med Res; 2019 Feb; 47(2):884-892. PubMed ID: 30632430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epitope Mapping of SERCA2a Identifies an Antigenic Determinant That Induces Mainly Atrial Myocarditis in A/J Mice.
    Krishnan B; Massilamany C; Basavalingappa RH; Gangaplara A; Rajasekaran RA; Afzal MZ; Khalilzad-Sharghi V; Zhou Y; Riethoven JJ; Nandi SS; Mishra PK; Sobel RA; Strande JL; Steffen D; Reddy J
    J Immunol; 2018 Jan; 200(2):523-537. PubMed ID: 29229678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Connexin 43 gene therapy prevents persistent atrial fibrillation in a porcine model.
    Bikou O; Thomas D; Trappe K; Lugenbiel P; Kelemen K; Koch M; Soucek R; Voss F; Becker R; Katus HA; Bauer A
    Cardiovasc Res; 2011 Nov; 92(2):218-25. PubMed ID: 21799069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.